Atopic Dermatitis With a Focus on Moderate to Severe Disease

Atopic dermatitis (AD) affects nearly 10% of children and 7% of adults in the United States. Initial treatments for all patients with AD include vigilant skin hygiene and moisturizers. Other treatments, depending on disease severity, include topical corticosteroids, calcineurin inhibitors, or phototherapy as maintenance therapy to lengthen the time to relapse. Systemic immunosuppressants are recommended when these regimens are inadequate but are associated with poor side effect profiles. Recent discoveries are leading to more effective and safer immunomodulatory therapies.

Source: The Journal for Nurse Practitioners - October 19, 2020 Category: Nursing Authors: Lakshi M. Aldredge Tags: Feature Article Source Type: research